Seven-Part Pediatric Drug Development Webinar Series - Part 4: Dosing in Children

Speakers

Klaus Rose, MD, MS

Chief Executive Officer, klausrose Consulting, Switzerland

Klaus Rose, a German MD with postgraduate degrees in General & Pharmaceutical Medicine, was 20 years with Big Pharma. In 2001, he became Global Head Pediatrics at Novartis & 2005 at Roche ; CEO of klausrose Consulting since 2011. He advises on pediatric drug development and FDA/EMA pediatric requirements. Private interests: languages, classical guitar, cooking, wine & gardening

Adina Valeria Tocoian, MD

, F.Hoffmann-La Roche Ltd, Switzerland

Have an account?

Ways to register

Archived Webinar
Series Discount Available*
Buy 3 or more webinars in this series and save 15%
Buy 5 or more and save 20%
Buy the whole series and save 30%

*Order must be placed in one transaction for savings to be applied.

Group site registration is a license for ONE internet login allowing multiple viewers from one location.
Group Plus is a license for up to FIVE internet logins allowing one or more viewers at each login location.

CANCELLATIONS
No refunds will be provided in the event of a participant’s cancellation since all costs for this webinar have been prepaid by DIA. DIA reserves the right to modify or cancel programs and/or substitute presenters or panelists. DIA is not responsible for failure to deliver programs due to circumstances beyond its control.